Ocular Therapeutix

OCULNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.194 B

$9.99 +0.00%

Close of 21 Sept 2026

Revenue

$52.0M

#2718 by revenue

Earnings

-$265.9M

Loss-making

Shares outstanding

219,615,868

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#99Palvella TherapeuticsPVLA$2.21B
#100Aurinia PharmaceuticalsAUPH$2.21B
#101Ocular TherapeutixOCUL$2.19B
#102BiohavenBHVN$2.15B
#103Nuvation BioNUVB$2.13B

What if Ocular Therapeutix were worth as much as…

Open the what-if tool →

Gold $30.3T

$137,850.03

Per share 13,799× higher

Bitcoin $1.72T

$7,830.96

Per share 784× higher

Nvidia $5.48T

$24,952.01

Per share 2,498× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Ocular Therapeutix are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.